Cardiac injury in patients with pandemic 2009 influenza A (H1N1) infection

Acta Cardiologica

Volumn 66, Issue 4, 2011, Pages 427-432

  Ni, Ziying ^a   Guo, Zhidong ^a   Chen, Xi ^b   Wang, Qiqi ^b   Qiu, Yuangang ^b   Wu, Tao ^b   Yang, Yida ^b   Zhao, Lili ^b  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Heart injury; High sensitivity C reactive protein (hs CRP); Influenza A (H1N1)

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CHINA; CREATINE KINASE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HEART INJURY; HEART MUSCLE INJURY; HEART THORAX INDEX; HUMAN; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY;

ADULT; C-REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; RETROSPECTIVE STUDIES; TROPONIN I;

EID: 80052020904     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.4.2126589     Document Type: Article

References (16)

1. Mamas A, Doug F, Ludwig N. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 2008; 130: 304-309.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-1340.
3. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK; Expert Panel of the Infectious Diseases Society of America. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1003-1032.
4. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
5. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009; 9: 601-610.
6. CDC protocol of realtime RTPCR for swine influenza A (H1N1). Geneva: World Health Organization, April 28, 2009.
7. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302: 1880-1887.
8. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993; 87: 1542-1550.
9. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Centers for Disease Control and Prevention; American Heart Association. Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease. Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-4511.
10. Stewart S, Hart C L, Hole D J, McMurray J J V. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/ Paisley study. Heart 2001; 86: 516-521.
11. Onitsuka H, Imamura T, Miyamoto N, Shibata Y, Kashiwagi T, Ayabe T, Kawagoe J, Matsuda J, Ishikawa T, Unoki T, Takenaga M, Fukunaga T, Nakagawa S, Koiwaya Y, Eto T. Clinical manifestation of influenza A myocarditis during the influenza epidemic of winter 1998-1999. J Cardiol 2001; 37: 315-323.
12. Kol A, Libby P. Molecular mediators of arterial inflammation: a role for microbial products? Am Heart J 1999; 138: S450-S452.
13. The Eurowinter Group. Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. Lancet 1997; 349: 1341-1346.
14. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-2736.
15. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158: 1769-1776.
16. Christenson B, Lundbergh P, Hedlund J, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001; 357: 1008-1011.